Objectives. To evaluate the efficacy of filtration leucocytapheresis (LCP) for rheumatoid
arthritis (RA). Methods. LCP was carried out three times, with 1 week separating each …

Objective To determine the efficacy and safety of filtration leukocytapheresis (LCP) for the
treatment of rheumatoid arthritis (RA). Methods Twenty‐five patients with drug‐resistant RA …

This study was designed to determine the efficacy of filtration leukocytapheresis (LCAP) in
the treatment of rheumatoid arthritis (RA) and the mechanism of its efficacy. Three filtration …

We attempted to determine whether various cytokine levels in the serum and synovial fluid
(SF) of rheumatoid arthritis (RA) patients are influenced by the performance of filtration …

Filtration leukocytapheresis (LCP) is a treatment for abnormal autoimmune states, which
removes responsible leukocytes from the peripheral blood. To examine the efficacy of LCP …

The purpose of this study is to determine the changes in CD4+ T lymphocyte subsets in the
circulating blood and synovial fluid following filtration leukocytapheresis (LCP) therapy for …

To evaluate the efficacy of high-dose leukocytapheresis (LCAP) using a large filter in
patients with refractory rheumatoid arthritis (RA), we conducted a multicenter …

The present study was designed to determine the efficacy of filtration leukocytapheresis
(LCAP) in the treatment of rheumatoid arthritis (RA) with vasculitis. Nine RA patients with …

Several clinical trials have demonstrated that leukocytapheresis (LCAP) is a safe and
effective therapy for patients with refractory rheumatoid arthritis (RA). However, most of those …

A practical on–line lymphocytapheresis (LCP) system using a leukapheresis filter
(Cellsorba, Asahi Medical Co.) was evaluated in six patients with refractory rheumatoid …